2020
DOI: 10.24835/1607-0763-2020-2-63-77
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of lung damage in pneumonia, from chest magnetic resonance imaging, in primary diagnosis and in the follow-up of treatment

Abstract: Purpose of the study. To evaluate the practical significance of MRI in the primary diagnosis of inflammatory lung diseases, as well as in follow-up control of treatment, also in comparison with the results of CT of the chest.Material and Methods. In 25 patients with acute pneumonia, six of them with acute myocardial infarction developed as complication of it, the MRI of the chest organs was performed in T1 - and T2-weighted (-w.) modes, also with fat signal suppression, with slice thickness of 2.5 to 5 mm, in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 7 publications
2
4
0
Order By: Relevance
“…A third of our respondents had CVD despite the relatively young mean age of the people surveyed (~45 years). A significant COVID-19-history-associated increase in CVD morbidity occurred in the 40- to 49-year-old group of respondents, which agrees with observations that incident CVD may be a long-term outcome of COVID-19 infection [ 2 , 3 , 45 , 46 , 47 , 48 ]. Indeed, non-ischemic myocardial fibrosis, exceeding the prevalence in the normal adult population, was found in every third patient with clinical suspicion of cardiovascular post-acute sequelae of SARS-CoV-2 infection.…”
Section: Discussionsupporting
confidence: 88%
“…A third of our respondents had CVD despite the relatively young mean age of the people surveyed (~45 years). A significant COVID-19-history-associated increase in CVD morbidity occurred in the 40- to 49-year-old group of respondents, which agrees with observations that incident CVD may be a long-term outcome of COVID-19 infection [ 2 , 3 , 45 , 46 , 47 , 48 ]. Indeed, non-ischemic myocardial fibrosis, exceeding the prevalence in the normal adult population, was found in every third patient with clinical suspicion of cardiovascular post-acute sequelae of SARS-CoV-2 infection.…”
Section: Discussionsupporting
confidence: 88%
“…A third of our respondents had CVD relatively young mean age of the people surveyed (~45 years). A significant COVID-19 history-associated increase in CVD morbidity occurred in 40 to 49-year-old group of respondents, which agrees with observations that incident CVD may be a longterm outcome of COVID-19 infection [2,3,[30][31][32][33]. Indeed, non-ischemic myocardial fibrosis, exceeding the prevalence in the normal adult population, was found in every third patient with clinical suspicion of cardiovascular post-acute sequelae of SARS-CoV-2 infection.…”
Section: Discussionsupporting
confidence: 86%
“…COVID-19 pandemics posed new threats to general and cardiac health, and imaging services proved to be valuable in identifying emerging health problems [2,3,32,33]. Global COVID-19 pandemic put unprecedented pressure on the healthcare system worldwide.…”
Section: Discussionmentioning
confidence: 99%
“…The 2019 novel coronavirus infection (COVID-19) changed the profile of patients seeking primary medical care. Concomitant injury to the lungs and myocardium in COVID-19 was observed using magnetic resonance imaging (MRI) at the very beginning of the COVID-19 pandemic [ 1 , 2 , 3 , 4 ]. Recent data showed that the number of patients with heart problems indeed significantly increased during the COVID-19 pandemic [ 5 , 6 , 7 , 8 ].…”
Section: Introductionmentioning
confidence: 99%